John T. Henderson, Director at CYTOKINETICS INC (CYTK), sold 858 shares at $20.31 ($17K) on 2020-12-31, disclosed to the SEC on 2020-12-31.
Scheduled sale ($17k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CYTK | SELL | 2025-04-16 | $247K | — | Filing → |
| CYTK | SELL | 2024-12-12 | $179K | — | Filing → |
| CYTK | SELL | 2024-04-25 | $1.4M | — | Filing → |